Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Código da empresaSNY
Nome da EmpresaSanofi SA
Data de listagemJul 01, 2002
Fundado em1994
CEOMr. Paul Hudson, Ph.D.
Número de funcionários84587
Tipo de títulosDepository Receipt
Fim do ano fiscalJul 01
Endereço46 Avenue de la Grande Armee
CidadePARIS
Bolsa de valoresNASDAQ Global Select Consolidated
PaísFrance
Código postal75017
Telefone33153774000
Sitehttps://www.sanofi.com/
Código da empresaSNY
Data de listagemJul 01, 2002
Fundado em1994
Um total de
23.51B
USD foi distribuído em dividendos nos últimos 5 anos.
SNY.NB Final Cash Dividend of gross USD 2.036908 paid on Jun 06, 2024 going ex on May 09, 2024
SNY.NB Final Cash Dividend of gross USD 1.900085 paid on Jun 23, 2023 going ex on May 30, 2023
SNY.NB Final Cash Dividend of gross USD 1.74684 paid on May 31, 2022 going ex on May 04, 2022
SNY.NB Final Cash Dividend of gross USD 1.928784 paid on May 26, 2021 going ex on May 03, 2021
SNY.NB Final Cash Dividend of gross USD 1.699399 paid on May 26, 2020 going ex on Apr 30, 2020